166 related articles for article (PubMed ID: 16181753)
21. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
[TBL] [Abstract][Full Text] [Related]
22. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
Zhu B; Traini D; Chan HK; Young PM
Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
[TBL] [Abstract][Full Text] [Related]
23. On the Feasibility of Rugose Lipid Microparticles in Pressurized Metered Dose Inhalers with Established and New Propellants.
Minootan Z; Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Martin AR; Vehring R
AAPS PharmSciTech; 2024 Apr; 25(4):82. PubMed ID: 38600288
[TBL] [Abstract][Full Text] [Related]
24. Compare and contrast the effects of surfactants (PluronicF-127 and CremophorEL) and sugars (β-cyclodextrin and inulin) on properties of spray dried and crystallised lysozyme.
Haj-Ahmad RR; Elkordy AA; Chaw CS; Moore A
Eur J Pharm Sci; 2013 Jul; 49(4):519-34. PubMed ID: 23712374
[TBL] [Abstract][Full Text] [Related]
25. The effect of reduction of propellant mass fraction on the injection profile of metered dose inhalers.
Ju D; Shrimpton J; Hearn A
Int J Pharm; 2010 May; 391(1-2):221-9. PubMed ID: 20227471
[TBL] [Abstract][Full Text] [Related]
26. ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.
McCabe JC; Koppenhagen F; Blair J; Zeng XM
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):104-9. PubMed ID: 22191397
[TBL] [Abstract][Full Text] [Related]
27. Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers.
Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
Eur J Pharm Biopharm; 2012 May; 81(1):74-81. PubMed ID: 22245573
[TBL] [Abstract][Full Text] [Related]
28. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Peyron ID; Britto IL; Benissan LB; Tardieu BZ
Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
[TBL] [Abstract][Full Text] [Related]
29. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
30. Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane-based metered dose inhalers.
Myrdal PB; Karlage KL; Stein SW; Brown BA; Haynes A
J Pharm Sci; 2004 Apr; 93(4):1054-61. PubMed ID: 14999741
[TBL] [Abstract][Full Text] [Related]
31. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
Kleinstreuer C; Shi H; Zhang Z
J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
[TBL] [Abstract][Full Text] [Related]
32. Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants.
Shan Z; Tan Y; Qin L; Li G; Pan X; Wang Z; Yu X; Wang Q; Wu C
Int J Pharm; 2014 May; 466(1-2):390-9. PubMed ID: 24657140
[TBL] [Abstract][Full Text] [Related]
33. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery.
Ogáin ON; Li J; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Feb; 405(1-2):23-35. PubMed ID: 21129458
[TBL] [Abstract][Full Text] [Related]
34. Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen.
Buttini F; Glieca S; Sonvico F; Lewis DA
Expert Opin Drug Deliv; 2023; 20(8):1131-1143. PubMed ID: 37767756
[TBL] [Abstract][Full Text] [Related]
35. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations.
D'Sa DJ; Lechuga-Ballesteros D; Chan HK
Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449
[TBL] [Abstract][Full Text] [Related]
36. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
Smyth HD; Hickey AJ
AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
[TBL] [Abstract][Full Text] [Related]
37. Amorphous pullulan trehalose microparticle platform for respiratory delivery.
Carrigy NB; Ordoubadi M; Liu Y; Melhem O; Barona D; Wang H; Milburn L; Ruzycki CA; Finlay WH; Vehring R
Int J Pharm; 2019 May; 563():156-168. PubMed ID: 30951858
[TBL] [Abstract][Full Text] [Related]
38. The rejuvenated pressurised metered dose inhaler.
Bell J; Newman S
Expert Opin Drug Deliv; 2007 May; 4(3):215-34. PubMed ID: 17489650
[TBL] [Abstract][Full Text] [Related]
39. Influence of the valve lubricant on the aerodynamic particle size of a metered dose inhaler.
Berry J; Kline L; Naini V; Chaudhry S; Hart J; Sequeira J
Drug Dev Ind Pharm; 2004 Mar; 30(3):267-75. PubMed ID: 15109026
[TBL] [Abstract][Full Text] [Related]
40. Reformulation of Stmerin(®) D CFC formulation using HFA propellants.
Murata S; Izumi T; Ito H
Pharm Dev Technol; 2013; 18(6):1314-8. PubMed ID: 22519407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
